{
  "primary": "PML",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 has been shown to interact with the Promyelocytic leukemia protein (PML), a component of nuclear bodies, suggesting a role in transcriptional regulation or protein degradation within these subnuclear structures.",
  "functions": [
    {
      "function": "Inhibition of Deubiquitinating (DUB) Activity",
      "arrow": "activates",
      "cellular_process": "The Promyelocytic leukemia protein (PML) isoform II specifically recruits ATXN3 to subnuclear structures known as PML nuclear bodies (PML-NBs), where it modulates ATXN3's enzymatic function.",
      "effect_description": "Upon recruitment to PML-NBs through a direct interaction with the unique C-terminal region of the PML-II isoform, the deubiquitinase (DUB) activity of ATXN3 is inhibited. This sequestration and inactivation mechanism suggests that PML-NBs function as regulatory hubs to control the local activity of ATXN3 within the nucleus.",
      "biological_consequence": [
        "PML-II isoform binds to ATXN3 via its unique C-terminal domain → ATXN3 is recruited and sequestered into PML Nuclear Bodies → The deubiquitinase activity of ATXN3 is inhibited → Ubiquitination levels of local ATXN3 substrates are altered."
      ],
      "specific_effects": [
        "The interaction is specific to the PML-II isoform and is not observed with other PML isoforms.",
        "PML-II binds to both the normal (13Q) and the pathological, polyQ-expanded (79Q) forms of ataxin-3.",
        "The binding of ATXN3 occurs specifically at the C-terminal region of PML-II."
      ],
      "evidence": [
        {
          "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
          "journal": "Biochemical and Biophysical Research Communications",
          "year": 2021,
          "relevant_quote": "Here, we report the characterization of the deubiquitinase ataxin-3 as a specific binding partner of PML isoform II (PML-II)... Importantly, the deubiquitinase activity of ataxin-3 was inhibited by PML-II. Our results suggest that PML-II may be a negative regulator of ataxin-3.",
          "pmid": "33798946"
        }
      ],
      "pathway": {
        "name": "Post-Translational Modification",
        "canonical_name": "Post-Translational Modification",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "33798946"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim is accurate but lacks specificity regarding the direction of inhibition. The PML-II isoform recruits and inhibits the deubiquitinating activity of ATXN3. The arrow of interaction should therefore be directed from PML to ATXN3.",
  "mechanism": "The Promyelocytic leukemia protein (PML) isoform II specifically recruits ATXN3 to subnuclear structures known as PML nuclear bodies (PML-NBs), where it modulates ATXN3's enzymatic function.",
  "effect": "Upon recruitment to PML-NBs through a direct interaction with the unique C-terminal region of the PML-II isoform, the deubiquitinase (DUB) activity of ATXN3 is inhibited. This sequestration and inactivation mechanism suggests that PML-NBs function as regulatory hubs to control the local activity of ATXN3 within the nucleus.",
  "summary": "ATXN3 inhibits PML to modulate inhibition of deubiquitinating (dub) activity, ultimately affecting ubiquitination levels of local atxn3 substrates are altered.",
  "evidence": [
    {
      "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2021,
      "relevant_quote": "Here, we report the characterization of the deubiquitinase ataxin-3 as a specific binding partner of PML isoform II (PML-II)... Importantly, the deubiquitinase activity of ataxin-3 was inhibited by PML-II. Our results suggest that PML-II may be a negative regulator of ataxin-3."
    }
  ],
  "pathways": [
    {
      "name": "Post-Translational Modification",
      "canonical_name": "Post-Translational Modification",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- PML:",
  "protein_a": "ATXN3",
  "protein_b": "PML",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-08T02:27:47.347113Z",
  "last_updated": "2025-12-08T02:27:47.347113Z"
}